Postoperative management for non-small cell lung cancer harboring EGFR mutations

por Tanaka, Fumihiro, Yoneda, Kazue, Takenaka, Masaru
Publicado 2020

Treatment strategy of EGFR-mutated non-small cell lung cancer

por Tanaka, Fumihiro, Yoneda, Kazue, Takenaka, Masaru, Kuroda, Koji
Publicado 2022

Circulating Tumor Cell Count Can Be a Useful Prognostic Factor in Lung Resection via Cardiopulmonary Bypass

por Hashimoto, Masaki, Okumura, Yoshitomo, Tanaka, Fumihiro, Yoneda, Kazue, Takuwa, Teruhisa, Kondo, Nobuyuki, Hasegawa, Seiki
Publicado 2017

Major pathologic response to alectinib in ALK-rearranged adenocarcinoma of the lung

por Imanishi, Naoko, Yoneda, Kazue, Taira, Akihiro, Ichiki, Yoshinobu, Sato, Naoko, Hisaoka, Masanori, Tanaka, Fumihiro
Publicado 2018

Detection of Circulating Tumor Cells (CTCs) in Malignant Pleural Mesothelioma (MPM) with the “Universal” CTC-Chip and An Anti-Podoplanin Antibody NZ-1.2

por Kuwata, Taiji, Yoneda, Kazue, Mori, Masataka, Kanayama, Masatoshi, Kuroda, Koji, K. Kaneko, Mika, Kato, Yukinari, Tanaka, Fumihiro
Publicado 2020

Alteration in tumoural PD-L1 expression and stromal CD8-positive tumour-infiltrating lymphocytes after concurrent chemo-radiotherapy for non-small cell lung cancer

por Yoneda, Kazue, Kuwata, Taiji, Kanayama, Masatoshi, Mori, Masataka, Kawanami, Toshinori, Yatera, Kazuhiro, Ohguri, Takayuki, Hisaoka, Masanori, Nakayama, Toshiyuki, Tanaka, Fumihiro
Publicado 2019

Prognostic impact of PD-L1 expression in correlation with neutrophil-to-lymphocyte ratio in squamous cell carcinoma of the lung

por Tashima, Yuko, Kuwata, Taiji, Yoneda, Kazue, Hirai, Ayako, Mori, Masataka, Kanayama, Masatoshi, Imanishi, Naoko, Kuroda, Koji, Ichiki, Yoshinobu, Tanaka, Fumihiro
Publicado 2020

CD155 expression and its clinical significance in non-small cell lung cancer

por Oyama, Rintaro, Kanayama, Masatoshi, Mori, Masataka, Matsumiya, Hiroki, Taira, Akihiro, Shinohara, Shinji, Takenaka, Masaru, Yoneda, Kazue, Kuroda, Koji, Tanaka, Fumihiro
Publicado 2022

Circulating Tumor Cells as an Indicator of Postoperative Lung Cancer: A Case Report

por Kuwata, Taiji, Yoneda, Kazue, Kobayashi, Kenichi, Oyama, Rintarou, Matumiya, Hiroki, Shinohara, Shuichi, Takenaka, Masaru, Oka, Soichi, Chikaishi, Yasuhiro, Inanishi, Naoko, Kuroda, Koji, Tanaka, Fumihiro
Publicado 2016

Achievement of Cure with Gefitinib in Advanced Lung Adenocarcinoma Harboring an Activating EGFR Mutation: A Case Report

por Kuwata, Taiji, Yoneda, Kazue, Kobayashi, Kenichi, Oyama, Rintarou, Matumiya, Hiroki, Shinohara, Shuichi, Takenaka, Masaru, Oka, Soichi, Chikaishi, Yasuhiro, Imanishi, Naoko, Kuroda, Koji, Tanaka, Fumihiro
Publicado 2016

Novel circulating tumor cell-detection chip combining conventional podoplanin and EGFR antibodies for all histological malignant pleural mesothelioma

por Kanayama, Masatoshi, Oyama, Rintaro, Mori, Masataka, Taira, Akihiro, Shinohara, Shinji, Kuwata, Taiji, Takenaka, Masaru, Yoneda, Kazue, Kuroda, Koji, Ohnaga, Takashi, Kato, Yukinari, Tanaka, Fumihiro
Publicado 2021

Detection of circulating tumor cells with a novel microfluidic system in malignant pleural mesothelioma

por Yoneda, Kazue, Kuwata, Taiji, Chikaishi, Yasuhiro, Mori, Masataka, Kanayama, Masatoshi, Takenaka, Masaru, Oka, Soichi, Hirai, Ayako, Imanishi, Naoko, Kuroda, Koji, Ichiki, Yoshinobu, Ohnaga, Takashi, Tanaka, Fumihiro
Publicado 2019

Prognostic impact of circulating tumor cells detected with the microfluidic “universal CTC‐chip” for primary lung cancer

por Kanayama, Masatoshi, Kuwata, Taiji, Mori, Masataka, Nemoto, Yukiko, Nishizawa, Natsumasa, Oyama, Rintaro, Matsumiya, Hiroki, Taira, Akihiro, Shinohara, Shinji, Takenaka, Masaru, Yoneda, Kazue, Kuroda, Koji, Ohnaga, Takashi, Tanaka, Fumihiro
Publicado 2022

Prognostic impact of PD-L1 and TIGIT expression in non-small cell lung cancer following concurrent chemo-radiotherapy

por Mori, Masataka, Kanayama, Masatoshi, Kuwata, Taiji, Manabe, Takehiko, Nemoto, Yukiko, Nishizawa, Natsumasa, Oyama, Rintaro, Matsumiya, Hiroki, Nabe, Yusuke, Taira, Akihiro, Takenaka, Masaru, Yoneda, Kazue, Kuroda, Koji, Tanaka, Fumihiro
Publicado 2023

Mediastinal Tracheostoma for Treatment of Tracheostenosis after Tracheostomy in a Patient with Mucopolysaccharidosis-Induced Tracheomalacia

por Chikaishi, Yasuhiro, Kobayashi, Kenichi, Shinohara, Shuichi, Taira, Akihiro, Nabe, Yusuke, Shinohara, Shinji, Kuwata, Taiji, Takenaka, Masaru, Oka, Soichi, Hirai, Ayako, Yoneda, Kazue, Kuroda, Koji, Imanishi, Naoko, Ichiki, Yoshinobu, Tanaka, Fumihiro
Publicado 2017

Podoplanin: An emerging cancer biomarker and therapeutic target

por Krishnan, Harini, Rayes, Julie, Miyashita, Tomoyuki, Ishii, Genichiro, Retzbach, Edward P., Sheehan, Stephanie A., Takemoto, Ai, Chang, Yao‐Wen, Yoneda, Kazue, Asai, Jun, Jensen, Lasse, Chalise, Lushun, Natsume, Atsushi, Goldberg, Gary S.
Publicado 2018

Salvage surgery combined with descending aorta resection for lung cancer

por Kanayama, Masatoshi, Ichiki, Yoshinobu, Mori, Masataka, Matsumiya, Hiroki, Nabe, Yusuke, Taira, Akihiro, Shinohara, Shinji, Kuwata, Taiji, Takenaka, Masaru, Hirai, Ayako, Imanishi, Naoko, Yoneda, Kazue, Ikushima, Eigo, Yasutsune, Toru, Nishimura, Yosuke, Tanaka, Fumihiro
Publicado 2019

Fenestration without rib resection for postoperative bronchopleural fistula

por Kanayama, Masatoshi, Ichiki, Yoshinobu, Yoshimatsu, Katsuma, Takeda, Yusuke, Kusanagi, Kasumi, Ishida, Teruaki, Mori, Masataka, Matsumiya, Hiroki, Nabe, Yusuke, Taira, Akihiro, Shinohara, Shinji, Kuwata, Taiji, Takenaka, Masaru, Hirai, Ayako, Imanishi, Naoko, Yoneda, Kazue, Tanaka, Fumihiro
Publicado 2019

Adaptive resistance to lorlatinib via EGFR signaling in ALK-rearranged lung cancer

por Katayama, Yuki, Yamada, Tadaaki, Tanimura, Keiko, Tokuda, Shinsaku, Morimoto, Kenji, Hirai, Soichi, Matsui, Yohei, Nakamura, Ryota, Ishida, Masaki, Kawachi, Hayato, Yoneda, Kazue, Hosoya, Kazutaka, Tsuji, Takahiro, Ozasa, Hiroaki, Yoshimura, Akihiro, Iwasaku, Masahiro, Kim, Young Hak, Horinaka, Mano, Sakai, Toshiyuki, Utsumi, Takahiro, Shiotsu, Shinsuke, Takeda, Takayuki, Katayama, Ryohei, Takayama, Koichi
Publicado 2023

HER3 activation contributes toward the emergence of ALK inhibitor-tolerant cells in ALK-rearranged lung cancer with mesenchymal features

por Tanimura, Keiko, Yamada, Tadaaki, Okada, Koutaroh, Nakai, Kunihiro, Horinaka, Mano, Katayama, Yuki, Morimoto, Kenji, Ogura, Yuri, Takeda, Takayuki, Shiotsu, Shinsuke, Ichikawa, Kosuke, Watanabe, Satoshi, Morimoto, Yoshie, Iwasaku, Masahiro, Kaneko, Yoshiko, Uchino, Junji, Taniguchi, Hirokazu, Yoneda, Kazue, Matoba, Satoaki, Sakai, Toshiyuki, Uehara, Hisanori, Yano, Seiji, Kusaba, Tetsuro, Katayama, Ryohei, Takayama, Koichi
Publicado 2022